GPI-1485 (Guilford)
Marshall, V.L.; Grosset, D.G.
Current Opinion in Investigational Drugs 5(1): 107-112
2004
ISSN/ISBN: 1472-4472 PMID: 14983983 Document Number: 583586
GPI-1485 is a neuroimmunophilin ligand that binds to FK-506-binding proteins and is under development by Guilford for the potential treatment of erectile dysfunction following nerve injury during prostate resection and Parkinson's disease. In August 2002, phase II clinical trials investigating GPI-1485 for Parkinson's disease commenced, and in November 2003, further phase II trials commenced for post-prostatectomy erectile dysfunction.